Read about the Oxford Vaccine Centre’s COVID-19 vaccine trial.
Com-COV3: Vaccine study to research third dose booster options for 12-to-15 year-olds –find your closest study site and read the press release
Recruiting Now: Help us investigate the first ever vaccine for Invasive Non-Typhoid Salmonella (iNTS) – The SALVO Trial
If you are aged 18 to 55 years old, in good health and live in the Oxford area, then you may be eligible to take part.
Take part in a clinical trial – see a list of all the trials we are currently recruiting to.
Non-COVID research statement
The Oxford Vaccine Group will be continuing with some of our non-COVID research, particularly our paediatric studies, during the COVID-19 pandemic. This is because as part of these studies we give babies their routine primary immunisations on behalf of their GPs. This reduces the administrative burden on the NHS, allowing them to free up capacity and prioritise their workload to be focused on doing what is necessary to manage the response to the COVID-19 pandemic. The participants also benefit from having the vaccines in the safety of their homes or a convenient location.
Research
Vaccines are a key component of global health policy and are essential in the defence of the health of young children. Our research focuses on the development and evaluation of new and improved vaccines.
Events and Training
We are committed to providing high quality education and training, together with research updates for medical professionals and all those involved in the area of vaccines and paediatric and adult infectious diseases.
Get involved
There are a number of ways in which you can get involved in our research, inform our research and find out more about our work. To find out more about any of these options, follow the link below.
Latest publications
-
Inclusion of a dual signal sequence enhances the immunogenicity of a novel viral vectored vaccine against the capsular group B meningococcus.
Journal article
Sheerin D. et al, (2022), Cell Biosci, 12
-
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial.
Journal article
Li G. et al, (2022), Lancet, 399, 2212 - 2225
-
Immunogenicity of a single 4CMenB vaccine booster in adolescents 11 years after childhood immunisation.
Journal article
Rollier CS. et al, (2022), Vaccine
-
Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial.
Journal article
Shaw RH. et al, (2022), Lancet Respir Med
-
Viral vector vaccines.
Journal article
McCann N. et al, (2022), Curr Opin Immunol, 77
Upcoming events
IIC 2022 - Hot Topics In Infection And Immunity In Children
Thursday, 30 June 2022 to Saturday, 02 July 2022
IIC – The ESPID-Oxford Course is a residential training course covering topics in paediatric infection for paediatric infectious diseases trainees and trainers, and for all those who manage children with infections. This will be the 19th edition of the course.
Virtual Influenza Update Training
Wednesday, 21 September 2022, 10am to 12.30pm
This training is for general practice nurses and other health professionals who as part of their role already administer and promote / advise about influenza vaccines. The training will cover the theory of the influenza programme. ** Please note that we will not be covering the local logistics of delivering the 2022/23 influenza programme **